Evidence map›Paper›PMID 21372301›Full record

ArticleArteriosclerosis, thrombosis, and vascular biology2011

Macrophage-derived tumor necrosis factor-alpha is an early component of the molecular cascade leading to angiogenesis in response to aortic injury.

Giovanni Ligresti, Alfred C Aplin, Penelope Zorzi, Ann Morishita, Roberto F Nicosia

Open access · bronzeAbstract read
In one paragraph

Article in Arteriosclerosis, thrombosis, and vascular biology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 48 citations in OpenAlex.

  1. Review
  2. Serum-Free Mouse Aortic Ring Assay of Angiogenesis.Methods in molecular biology (Clifton, N.J.) · 2025
    Article
  3. Review
  4. Review
  5. VEGF signaling: Role in angiogenesis and beyond.Biochimica et biophysica acta. Reviews on cancer · 2024
    Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. RecombinantPharmaceutics · 2020
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. IL-17 in neonatal health and disease.American journal of reproductive immunology (New York, N.Y. : 1989) · 2018
    Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Giovanni LigrestiPathology and Laboratory Medicine Services, (S-113), Department of Veterans Affairs Puget Sound Health Care System, University of Washington, 1660 S Columbian Way, Seattle, WA 98108, USA.
Alfred C Aplin
Penelope Zorzi
Ann Morishita
Roberto F Nicosia
VA Puget Sound Health Care System · US

Funding

PARACRINE REGULATION OF ANGIOGENESIS BY MURAL CELLSR01HL052585 · NHLBI · UNIVERSITY OF WASHINGTON · PI NICOSIA, ROBERTO · 1995 to 2010
$2.3M
NHLBI NIH HHS HL52585NHLBI NIH HHS R01 HL052585
6 · The paper itself

Abstract

objectiveThe goal of this study was to define the role of tumor necrosis factor-α (TNFα) in the cascade of gene activation that regulates aortic angiogenesis in response to injury. METHODS AND

resultsAngiogenesis was studied by culturing rat or mouse aortic rings in collagen gels. Gene expression was evaluated by quantitative reverse transcription-polymerase chain reaction, microarray analysis, immunocytochemistry, and ELISA. TNFα gene disruption and recombinant TNFα or blocking antibodies against vascular endothelial growth factor (VEGF) or TNF receptors were used to investigate TNFα-mediated angiogenic mechanisms. Resident aortic macrophages were depleted with liposomal clodronate. Angiogenesis was preceded by overexpression of TNFα and TNFα-inducible genes. Studies with isolated cells showed that macrophages were the main source of TNFα. Angiogenesis, VEGF production, and macrophage outgrowth were impaired by TNFα gene disruption and promoted by exogenous TNFα. Antibody-mediated inhibition of TNF receptor 1 significantly inhibited angiogenesis. The proangiogenic effect of TNFα was suppressed by blocking VEGF or by ablating aortic macrophages. Exogenous TNFα, however, maintained a limited proangiogenic capacity in the absence of macrophages and macrophage-mediated VEGF production.

conclusionsOverexpression of TNFα is required for optimal VEGF production and angiogenesis in response to injury. This TNFα/VEGF-mediated angiogenic pathway requires macrophages. The residual capacity of TNFα to stimulate angiogenesis in macrophage-depleted aortic cultures implies the existence of a VEGF-independent alternate pathway of TNFα-induced angiogenesis.

Indexed as

Neovascularization, PhysiologicSignal TransductionAnimalsAntibodiesAorta, ThoracicBlotting, WesternCells, CulturedClodronic AcidEnzyme-Linked Immunosorbent AssayGene Expression ProfilingGene Expression RegulationImmunohistochemistryMacrophagesMaleMiceMice, KnockoutAntibodiesClodronic AcidReceptors, Tumor Necrosis Factor, Type IReceptors, Tumor Necrosis Factor, Type IIRecombinant ProteinsRNA, MessengerTnfrsf1a protein, mouseTumor Necrosis Factor-alphaVascular Endothelial Growth Factor Avascular endothelial growth factor A, mousevascular endothelial growth factor A, rat

Identifiers

PMID21372301
PMCPMC3113655
OpenAlexW2075584620

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.